thiotepa has been researched along with Adenopathy in 1 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kodama, Y | 1 |
| Saburi, M | 1 |
| Maruyama, R | 1 |
| Sakata, M | 1 |
| Takata, H | 1 |
| Miyazaki, Y | 1 |
| Kawano, K | 1 |
| Wada, J | 1 |
| Urabe, S | 1 |
| Hazuku, T | 1 |
| Ohtsuka, E | 1 |
1 other study available for thiotepa and Adenopathy
| Article | Year |
|---|---|
[Busulfan/thiotepa followed by autologous peripheral blood stem cell transplantation for refractory diffuse large B-cell lymphoma accompanied by hypopyon].
Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cyclophosphamide; Doxorubicin; Humans; Lym | 2022 |